Find out more about Rachel Koldej's experience
Rachel Koldej's highlights
FEATURED Journal article
A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study.
Read moreRachel Koldej's selected work
Circulating microRNA as a biomarker in brain cancer
Research Grant
A phase 1 clinical trial of the repurposable acetyllysine mimetic, n-methyl-2-pyrrolidone ..
Journal article
ALLG AMLM26 Phase 1B/2 Study Investigating Novel Therapies to Target Early Relapse and Clo..
Journal article
High Deliverability of a Midostaurin Triplet Regimen Incorporating Venetoclax and Low Dose..
Journal article
Immunologic Basis to Poor Graft Function Following Allogeneic Stem Cell Transplantation
Journal article
Time-Limited Ibrutinib and Tisagenlecleucel Is Highly Effective in the Treatment of Patien..
Journal article
Rachel Koldej's selected work
Projects
Displaying the 1 most recent project from 1 for Rachel Koldej.
Project Types
1
Research Grant
Scholarly Works
Displaying the 10 most recent scholarly works from 67 for Rachel Koldej.
Credentials
Positions
Honorary
Medicine - Royal Melbourne Hospital
Education
Bachelor of Biotechnology with honours
Flinders University of South Australia
Doctor of Philosophy
Adelaide University